SEC Insider Transactions from Barrett Elizabeth A..

Last updated: 2026-03-14 11:50 UTC | Total transactions: 10

Barrett Elizabeth A. has filed 10 insider transactions across 3 companies since June 2023.

Most recent transaction: a grant/award of 153195 shares of UroGen Pharma Ltd. ($URGN) on January 31, 2026.

Set Up your own filters →
Transaction Date Company Ticker Insider Name Title Transaction Type Security Shares Price Shares Owned Following Total Shares Outstanding % of Owned % of Outstanding
Jan. 31, 2026 UroGen Pharma Ltd. $URGN Barrett Elizabeth A. Chief Executive Officer A Restricted Stock Units 153195 $0.00 153,195.0000 48,057,386 9999.99% 0.32%
July 31, 2025 Sage Therapeutics, Inc. $SAGE Barrett Elizabeth A. Not found D Stock Option (Right to Buy) 21500 $0.00 0.0000 62,784,397 100.00% 0.03%
July 31, 2025 Sage Therapeutics, Inc. $SAGE Barrett Elizabeth A. Not found U Common Stock 3000 $0.00 0.0000 62,784,397 100.00% 0.00%
July 28, 2025 UroGen Pharma Ltd. $URGN Barrett Elizabeth A. Chief Executive Officer A Performance Stock Units 87615 $0.00 87,615.0000 47,030,820 9999.99% 0.19%
June 18, 2025 Allogene Therapeutics, Inc. $ALLO Barrett Elizabeth A. Director A Restricted Stock Unit 95400 $0.00 95,400.0000 217,264,738 9999.99% 0.04%
June 11, 2025 Sage Therapeutics, Inc. $SAGE Barrett Elizabeth A. Not found A Stock Option (Right to Buy) 21500 $0.00 21,500.0000 61,480,947 9999.99% 0.03%
Jan. 31, 2025 UroGen Pharma Ltd. $URGN Barrett Elizabeth A. Chief Executive Officer A Restricted Stock Units 96377 $0.00 96,377.0000 47,030,820 9999.99% 0.20%
June 5, 2024 Allogene Therapeutics, Inc. $ALLO Barrett Elizabeth A. Not found A Stock Option (Right to buy) 191082 $0.00 191,082.0000 0 9999.99% 0.00%
Jan. 31, 2024 UroGen Pharma Ltd. $URGN Barrett Elizabeth A. Chief Executive Officer A Restricted Stock Units 87615 $0.00 87,615.0000 36,153,634 9999.99% 0.24%
June 13, 2023 Allogene Therapeutics, Inc. $ALLO Barrett Elizabeth A. Not found A Stock Option (Right to Buy) 116120 $0.00 116,120.0000 0 9999.99% 0.00%